<VariationArchive VariationID="1709095" VariationName="NM_001029896.2(WDR45):c.787_790dup (p.Phe264fs)" VariationType="Duplication" Accession="VCV001709095" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1707449" VariationID="1709095">
      <GeneList>
        <Gene Symbol="WDR45" FullName="WD repeat domain 45" GeneID="11152" HGNC_ID="HGNC:28912" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49074442" stop="49101178" display_start="49074442" display_stop="49101178" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NW_025791820.1" start="233393" stop="260129" display_start="233393" display_stop="260129" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48932091" stop="48958058" display_start="48932091" display_stop="48958058" Strand="-" />
          </Location>
          <OMIM>300526</OMIM>
          <Haploinsufficiency last_evaluated="2015-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WDR45">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WDR45">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001029896.2(WDR45):c.787_790dup (p.Phe264fs)</Name>
      <CanonicalSPDI>NC_000023.11:49075400:AGATA:AGATAGATA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49075400" stop="49075401" display_start="49075400" display_stop="49075401" variantLength="4" positionVCF="49075400" referenceAlleleVCF="A" alternateAlleleVCF="AAGAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48933059" stop="48933060" display_start="48933059" display_stop="48933060" variantLength="4" positionVCF="48933059" referenceAlleleVCF="A" alternateAlleleVCF="AAGAT" />
      </Location>
      <ProteinChange>F264fs</ProteinChange>
      <ProteinChange>F265fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48933061_48933064dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48933061_48933064dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.49075402_49075405dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.49075402_49075405dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033004.2" sequenceAccession="NG_033004" sequenceVersion="2" change="g.30767_30770dup">
            <Expression>NG_033004.2:g.30767_30770dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001029896.2" sequenceAccession="NM_001029896" sequenceVersion="2" change="c.787_790dup" MANESelect="true">
            <Expression>NM_001029896.2:c.787_790dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001025067.1" sequenceAccession="NP_001025067" sequenceVersion="1" change="p.Phe264fs">
            <Expression>NP_001025067.1:p.Phe264fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007075.4" sequenceAccession="NM_007075" sequenceVersion="4" change="c.790_793dup">
            <Expression>NM_007075.4:c.790_793dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009006.2" sequenceAccession="NP_009006" sequenceVersion="2" change="p.Phe265fs">
            <Expression>NP_009006.2:p.Phe265fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001029896.2(WDR45):c.787_790dup (p.Phe264fs) AND Neurodegeneration with brain iron accumulation 5" Accession="RCV002288379" Version="2">
        <ClassifiedConditionList TraitSetID="9501">
          <ClassifiedCondition DB="MedGen" ID="C3550973">Neurodegeneration with brain iron accumulation 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9501" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17735" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation 5</ElementValue>
                <XRef ID="MONDO:0010476" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Beta-propeller protein-associated neurodegeneration</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA5</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BPAN</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SENDA</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beta-propeller protein-associated neurodegeneration (BPAN) is typically characterized by early-onset seizures, infantile-onset developmental delay, intellectual disability, absent-to-limited expressive language, motor dysfunction (ataxia), and abnormal behaviors often similar to autism spectrum disorder. Seizure types including generalized (absence, tonic, atonic, tonic-clonic and myoclonic), focal with impaired consciousness, and epileptic spasms, as well as epileptic syndromes (West syndrome and Lennox-Gastaut syndrome) can be seen. With age seizures tend to resolve or become less prominent, whereas cognitive decline and movement disorders (progressive parkinsonism and dystonia) emerge as characteristic findings.</Attribute>
                <XRef ID="NBK424403" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12570" />
                <XRef ID="12570" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28211668</ID>
                <ID Source="BookShelf">NBK424403</ID>
              </Citation>
              <XRef ID="329284" DB="Orphanet" />
              <XRef ID="C3550973" DB="MedGen" />
              <XRef ID="MONDO:0010476" DB="MONDO" />
              <XRef Type="MIM" ID="300894" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5041566" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_001029896.2:c.787_790dup|OMIM:300894" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002580656" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WDR45" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001029896.2:c.787_790dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300894" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS2_MOD, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5041566" TraitType="Disease" MappingType="XRef" MappingValue="300894" MappingRef="OMIM">
        <MedGen CUI="C3550973" Name="Neurodegeneration with brain iron accumulation 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

